Developer docs
API playgroundTry for free, no card

Search company profiles

Acro Biotech

Full company profile

uuid000jcf8

Namestring
Acro Biotech
Legal namestring
Acro Biotech, Inc.
Websiteurl
acrobiotech.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Acro Biotech, Inc. is a privately held diagnostic manufacturer founded in 2005 and headquartered at 4650 Arrow Highway, Suite D6, Montclair, California. The company designs, manufactures, and sells rapid diagnostic tests across eight vertical categories — COVID-19 respiratory infection, women's health, infectious disease, drugs of abuse, tumor markers, cardiac markers, veterinary, and other products — alongside a portfolio of supporting instruments including the ACO300 urine analyzer, AFR-600 fluorescence immunoassay analyzer, LF Reader lateral flow reader, and AHR-100 multi-parameter hemoglobin/cholesterol/uric acid/glucose meter. The underlying technology stack is rooted in lateral flow immunoassay chemistry, fluorescence-based quantitative immunoassay, and automated urine/blood analysis for point-of-care clinical use.

The company serves hospitals, clinics, laboratories, and other clinical and point-of-care healthcare settings via a direct sales model with a claimed global reach, supported by a North America operational footprint. The customer base spans seven distinct use-case segments: clinical healthcare providers, women's health testing, infectious disease testing, drugs of abuse screening, tumor marker screening, cardiac assessment, and veterinary diagnostics. Marketing is conducted primarily through the company's website and social channels (Facebook, LinkedIn, YouTube). Acro Biotech's COVID-19 tests are explicitly not authorized, cleared, or approved by the US FDA and are not distributed in the United States, which materially restricts US market access for that product line. The company is small (51–100 employees), operates without a parent company or disclosed institutional investors, and has no disclosed funding rounds, leadership changes, or M&A activity in the source data.

Short descriptiontext

Acro Biotech is a privately held, Montclair, California-based manufacturer of rapid diagnostic tests and supporting analyzers, serving clinical, point-of-care, and veterinary customers across women's health, infectious disease, cardiac, oncology, and substance abuse verticals via direct sales globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersRancho Cucamonga, United States
HQ citystring
Rancho Cucamonga
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rapid diagnostic tests, lateral flow immunoassays, point-of-care diagnostics, in-vitro diagnostic kits, fluorescence immunoassay analyzers
Industry4 codes
PRIMARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAAALAC
Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)
SECONDARYHLAMAFAI
Laboratory & Point-of-Care Diagnostic Devices (Analyzers, Test Kits, Microscopy)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Medical Devices & Supplies
SECONDARYCRADAMAK
Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
Product category
In-Vitro Diagnostics
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Acro Biotech manufactures and sells rapid diagnostic test kits across multiple clinical categories, including COVID-19, infectious disease, women's health, cardiac markers, tumor markers, drugs of abuse, and veterinary applications. It also designs and sells supporting diagnostic instruments such as urine analyzers, a fluorescence immunoassay analyzer, a lateral flow reader, and a multi-parameter Hb/cholesterol/uric acid/glucose meter, intended for clinical, point-of-care, and home use.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Acro Biotech is a manufacturer of rapid diagnostic tests and medical instruments. The product portfolio includes multiple categories of rapid test kits (COVID-19, Women's Health, Infectious Disease, Drugs of Abuse, Tumor Markers, Cardiac Markers, Others, and Veterinary) alongside supporting diagnostic instruments including the ACO300 Urine Analyzer, AFR-600 Fluorescence Immunoassay Analyzer, LF Reader, and AHR-100 multi-parameter meter. The company operates from Montclair, California and serves the United States market with these diagnostic products.

Product and service1 record
1COVID-19 Tests
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major U.S. diagnostics incumbent offering a broad portfolio of rapid immunoassays, lateral flow tests, and immunoassay analyzers spanning infectious disease, women's health, and cardiac markers — directly overlapping Acro Biotech's product categories but at significantly larger scale.

2Abbott Rapid Diagnostics
TypeBroad incumbent
Description

Global leader in rapid diagnostics (Binax, Panbio, Determine) covering infectious disease, cardiac, drugs of abuse, and women's health — competes head-to-head with Acro Biotech across nearly every product category.

TypeBroad incumbent
Description

Diversified medical technology company with a large diagnostics segment including rapid immunoassays, point-of-care analyzers, and clinical chemistry instruments — overlapping with Acro Biotech's instruments and rapid test kits.

TypeDirect peer
Description

China-based manufacturer of rapid diagnostic test kits covering infectious disease, drugs of abuse, cardiac markers, and women's health — a closely comparable mid-sized lateral flow test manufacturer competing with Acro Biotech in international markets.

TypeDirect peer
Description

Specialized rapid diagnostic test manufacturer producing lateral flow assays across infectious disease, fertility, drugs of abuse, and cardiac markers — a close head-to-head peer in product mix and OEM/private-label positioning.

6CTK Biotech
TypeDirect peer
Description

San Diego-based developer and manufacturer of rapid diagnostic tests for infectious diseases, women's health, drugs of abuse, and tumor markers — directly comparable in geography, scale, and product portfolio to Acro Biotech.

TypeDirect peer
Description

Small-cap rapid diagnostic manufacturer focused on point-of-care infectious disease and immunoassay tests — comparable in size and lateral flow focus, with similar commercial dynamics facing larger incumbents.

TypeDirect peer
Description

Manufacturer of rapid diagnostic tests and immunoassay analyzers for drugs of abuse, pregnancy, and infectious disease — closely mirrors Acro Biotech's combination of kits and benchtop analyzers.

TypeBroad incumbent
Description

Major women's health diagnostics company (Aptima, ThinPrep, Rapid fFN) with overlapping women's health and infectious disease testing portfolios — an established incumbent in several of Acro Biotech's target segments.

10Bioteke Corporation
TypeDirect peer
Description

Manufacturer of rapid diagnostic test kits including infectious disease, cardiac, fertility, and drugs of abuse panels, with both lateral flow and analyzer offerings — closely comparable in product breadth and international distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Acro Biotech

In-Vitro Diagnosticsacrobiotech.com

Acro Biotech is a privately held, Montclair, California-based manufacturer of rapid diagnostic tests and supporting analyzers, serving clinical, point-of-care, and veterinary customers across women's health, infectious disease, cardiac, oncology, and substance abuse verticals via direct sales globally.

What Acro Biotech does

Acro Biotech, Inc. is a privately held diagnostic manufacturer founded in 2005 and headquartered at 4650 Arrow Highway, Suite D6, Montclair, California. The company designs, manufactures, and sells rapid diagnostic tests across eight vertical categories — COVID-19 respiratory infection, women's health, infectious disease, drugs of abuse, tumor markers, cardiac markers, veterinary, and other products — alongside a portfolio of supporting instruments including the ACO300 urine analyzer, AFR-600 fluorescence immunoassay analyzer, LF Reader lateral flow reader, and AHR-100 multi-parameter hemoglobin/cholesterol/uric acid/glucose meter. The underlying technology stack is rooted in lateral flow immunoassay chemistry, fluorescence-based quantitative immunoassay, and automated urine/blood analysis for point-of-care clinical use.

The company serves hospitals, clinics, laboratories, and other clinical and point-of-care healthcare settings via a direct sales model with a claimed global reach, supported by a North America operational footprint. The customer base spans seven distinct use-case segments: clinical healthcare providers, women's health testing, infectious disease testing, drugs of abuse screening, tumor marker screening, cardiac assessment, and veterinary diagnostics. Marketing is conducted primarily through the company's website and social channels (Facebook, LinkedIn, YouTube). Acro Biotech's COVID-19 tests are explicitly not authorized, cleared, or approved by the US FDA and are not distributed in the United States, which materially restricts US market access for that product line. The company is small (51–100 employees), operates without a parent company or disclosed institutional investors, and has no disclosed funding rounds, leadership changes, or M&A activity in the source data.

Acro Biotech firmographics

Firmographics
Name
Acro Biotech
Legal name
Acro Biotech, Inc.
Website
https://acrobiotech.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
51–100 employees
Short description
Acro Biotech is a privately held, Montclair, California-based manufacturer of rapid diagnostic tests and supporting analyzers, serving clinical, point-of-care, and veterinary customers across women's health, infectious disease, cardiac, oncology, and substance abuse verticals via direct sales globally.
Ownership category
akta.pro rank

Acro Biotech industry classification

Industry
Product category
In-Vitro Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAAALAC
Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)
SECONDARYHLAMAFAI
Laboratory & Point-of-Care Diagnostic Devices (Analyzers, Test Kits, Microscopy)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Medical Devices & Supplies
SECONDARYCRADAMAK
Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

  • Rapid diagnostic tests
  • Lateral flow immunoassays
  • Point-of-care diagnostics
  • In-vitro diagnostic kits
  • Fluorescence immunoassay analyzers

Where Acro Biotech is headquartered

Location

Headquarters

HQ city
Rancho Cucamonga
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Acro Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels3 records

Acro Biotech product offering

Product offering

Core offering

Acro Biotech manufactures and sells rapid diagnostic test kits across multiple clinical categories, including COVID-19, infectious disease, women's health, cardiac markers, tumor markers, drugs of abuse, and veterinary applications. It also designs and sells supporting diagnostic instruments such as urine analyzers, a fluorescence immunoassay analyzer, a lateral flow reader, and a multi-parameter Hb/cholesterol/uric acid/glucose meter, intended for clinical, point-of-care, and home use.

Product overview

Acro Biotech is a manufacturer of rapid diagnostic tests and medical instruments. The product portfolio includes multiple categories of rapid test kits (COVID-19, Women's Health, Infectious Disease, Drugs of Abuse, Tumor Markers, Cardiac Markers, Others, and Veterinary) alongside supporting diagnostic instruments including the ACO300 Urine Analyzer, AFR-600 Fluorescence Immunoassay Analyzer, LF Reader, and AHR-100 multi-parameter meter. The company operates from Montclair, California and serves the United States market with these diagnostic products.

Differentiator

Problem solved

Functional benefit

Products and services

  • COVID-19 Tests

Companies that use Acro Biotech

Customer profile

Segments7 records

Ideal customer profiles2 records

Acro Biotech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Acro Biotech partnerships and signals

Strategic signal

Recent moves4 records

Expansion highlights4 records

Acro Biotech competitors and assessment

Company assessment

Broad incumbents

  • QuidelOrtho: Major U.S. diagnostics incumbent offering a broad portfolio of rapid immunoassays, lateral flow tests, and immunoassay analyzers spanning infectious disease, women's health, and cardiac markers — directly overlapping Acro Biotech's product categories but at significantly larger scale.
  • Abbott Rapid Diagnostics: Global leader in rapid diagnostics (Binax, Panbio, Determine) covering infectious disease, cardiac, drugs of abuse, and women's health — competes head-to-head with Acro Biotech across nearly every product category.
  • Becton Dickinson (BD): Diversified medical technology company with a large diagnostics segment including rapid immunoassays, point-of-care analyzers, and clinical chemistry instruments — overlapping with Acro Biotech's instruments and rapid test kits.
  • Hologic: Major women's health diagnostics company (Aptima, ThinPrep, Rapid fFN) with overlapping women's health and infectious disease testing portfolios — an established incumbent in several of Acro Biotech's target segments.

Direct peers

  • Wondfo Biotech: China-based manufacturer of rapid diagnostic test kits covering infectious disease, drugs of abuse, cardiac markers, and women's health — a closely comparable mid-sized lateral flow test manufacturer competing with Acro Biotech in international markets.
  • Hangzhou AllTest Biotech: Specialized rapid diagnostic test manufacturer producing lateral flow assays across infectious disease, fertility, drugs of abuse, and cardiac markers — a close head-to-head peer in product mix and OEM/private-label positioning.
  • CTK Biotech: San Diego-based developer and manufacturer of rapid diagnostic tests for infectious diseases, women's health, drugs of abuse, and tumor markers — directly comparable in geography, scale, and product portfolio to Acro Biotech.
  • Chembio Diagnostics: Small-cap rapid diagnostic manufacturer focused on point-of-care infectious disease and immunoassay tests — comparable in size and lateral flow focus, with similar commercial dynamics facing larger incumbents.
  • Princeton BioMeditech: Manufacturer of rapid diagnostic tests and immunoassay analyzers for drugs of abuse, pregnancy, and infectious disease — closely mirrors Acro Biotech's combination of kits and benchtop analyzers.
  • Bioteke Corporation: Manufacturer of rapid diagnostic test kits including infectious disease, cardiac, fertility, and drugs of abuse panels, with both lateral flow and analyzer offerings — closely comparable in product breadth and international distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Acro Biotech social profiles

Digital presence

Acro Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Acro Biotech leadership team

Management profile

Number of profiles

Acro Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Acro Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Acro Biotech

What does Acro Biotech do?

Acro Biotech manufactures and sells rapid diagnostic test kits across multiple clinical categories, including COVID-19, infectious disease, women's health, cardiac markers, tumor markers, drugs of abuse, and veterinary applications. It also designs and sells supporting diagnostic instruments such as urine analyzers, a fluorescence immunoassay analyzer, a lateral flow reader, and a multi-parameter Hb/cholesterol/uric acid/glucose meter, intended for clinical, point-of-care, and home use.

Is Acro Biotech a public or private company?

Acro Biotech is a private company. It is classified as unknown and is currently operating.

When was Acro Biotech founded?

Acro Biotech was founded in 2005. It employs 51 to 100 people.

Where is Acro Biotech based?

Acro Biotech is headquartered in Rancho Cucamonga, United States, in the North America region.

Who are Acro Biotech's main competitors?

Broad incumbents on record are QuidelOrtho, Abbott Rapid Diagnostics, Becton Dickinson (BD) and Hologic. Direct peers are Wondfo Biotech, Hangzhou AllTest Biotech, CTK Biotech, Chembio Diagnostics, Princeton BioMeditech and Bioteke Corporation.

Does Acro Biotech have an API?

No public API is recorded for Acro Biotech.

What industry is Acro Biotech in?

Acro Biotech's product category is In-Vitro Diagnostics. Its primary akta.pro industry code is HLAHAOAK, Home-Use & OTC Rapid Self-Tests (Consumer POCT kits), with a secondary code of HLAAALAC, Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales